Key result
Perioperative ECMO linked to ~13-fold higher hospital mortality in infant truncus arteriosus repair.
Why the study?
Neonatal truncus arteriosus repair remains high risk with approximately 10% receiving perioperative ECMO, motivating an assessment of factors and outcomes associated with perioperative ECMO use.
Does perioperative ECMO use affect hospital mortality and outcomes in neonates and infants undergoing truncus arteriosus repair?
Cohort (n=1,645)
Yes
Does perioperative ECMO use affect hospital mortality and outcomes in neonates and infants undergoing truncus arteriosus repair?
Perioperative ECMO in neonates and infants undergoing truncus arteriosus repair is associated with significantly higher hospital mortality, prolonged length of stay, and increased 90-day readmission rates.
Answers are grounded in this paper and cite their sources.
ECMO use was associated with high mortality after truncus repair; Level 3 data leave open whether it identifies severity or alters outcomes.
Background: Despite surgical advances, neonatal truncus arteriosus repair remains high risk and approximately 10% of patients receive perioperative extracorporeal membrane oxygenation (ECMO). We aimed to assess factors and outcomes associated with the use of perioperative ECMO in infants undergoing truncus arteriosus repair. Methods: We conducted a retrospective cohort study of patients who underwent truncus arteriosus repair between 2004 and 2019, using administrative data from the Pediatric Health Information System database. Results: We identified 1,645 neonates and infants who underwent truncus arteriosus repair at 49 centers, of which 141 (8.6%) received ECMO. Prematurity (adjusted odds ratio [aOR], 2.06; 95% CI, 1.38-3.06; P < .001), truncal valve intervention (aOR, 4.69; 95% CI, 2.56-8.59; P < .001), and interrupted aortic arch repair (aOR, 1.80; 95% CI, 0.96-3.38; P = .07) were associated with perioperative ECMO. Hospital mortality occurred in 87 of 141 (62%) patients who received ECMO compared with 77/1504 (5.1%) who did not require ECMO(aOR, 13.39; 95% CI, 8.70-20.61; P < .001). In the 1,481 patients who survived to hospital discharge, ECMO was associated with higher rates of postoperative length of stay >30 days (63% [34/54] vs 28% [400/1427]; aOR 2.65; 95% CI, 1.24-5.64, P = .012) and hospital readmission within 90 days (61% [33/54 [ vs 33% [474/1427] [; aOR, 2.66; 95% CI, 1.47-4.82; P = .001). Conclusions: Prematurity, truncal valve intervention, and interrupted aortic arch repair are important risk factors that could help predict the use of perioperative ECMO. Extracorporeal membrane oxygenation utilization is strongly associated with greater odds of hospital mortality, prolonged postoperative length of stay, and higher rates of hospital readmission in surviving patients.
No takes yet. Share an insight, caveat, or question.
Suh et al. (2024) conducted a cohort in Truncus arteriosus (n=1,645). Perioperative extracorporeal membrane oxygenation (ECMO) vs. No ECMO was evaluated on Hospital mortality (aOR 13.39, 95% CI 8.70-20.61, p=< .001). Perioperative ECMO in neonates and infants undergoing truncus arteriosus repair was associated with higher hospital mortality compared to no ECMO.
Synapse has enriched 10 related papers. Consider them for comparative context: